Melatonin concentration as a marker of the circadian phase in patients with obstructive sleep apnoea

Sleep Medicine

Volumn 13, Issue 2, 2012, Pages 167-171

  Papaioannou, Ioannis ^a   Twigg, Gillian L ^a   Kemp, Michael ^b   Roughton, Michael ^b   Hooper, James ^b   Morrell, Mary J ^a,b   Polkey, Michael I ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Circadian rhythm; Dim light; Melatonin; Obstructive sleep apnoea; Sleep; Sleep disturbance

Indexed keywords

MELATONIN;

ADULT; ANTHROPOMETRY; APNEA HYPOPNEA INDEX; ARTICLE; BODY COMPOSITION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; MALE; OBSERVATIONAL STUDY; PARALLEL DESIGN; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALIVA ANALYSIS; SLEEP APNEA SYNDROME; SLEEP WAKING CYCLE;

ADULT; BIOLOGICAL MARKERS; CIRCADIAN RHYTHM; FEMALE; HUMANS; LIGHTING; MALE; MELATONIN; MIDDLE AGED; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; SALIVA; SLEEP APNEA, OBSTRUCTIVE; SLEEP DISORDERS;

EID: 84856503071     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2011.01.020     Document Type: Article

References (44)

1. Young T.D., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993, 328:1230-1235.
2. Jenkinson C., Davies R.J., Mullins R., Stradling J.R. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999, 353(9170):2100-2105.
3. Punjabi N.M., Caffo B.S., Goodwin J.L., et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6(8):e1000132.
4. Marin J., Carrizo S., Vicente E., Agusti A. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365(9464):1046-1053.
5. Chami H.A., Devereux R.B., Gottdiener J.S., et al. Left ventricular morphology and systolic function in sleep-disordered breathing: the sleep heart health study. Circulation 2008, 117(20):2599-2607.
6. Shahar E., Whitney C.W., Redline S., et al. Sleep-disordered breathing and cardiovascular disease. Cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med 2001, 163(1):19-25.
7. Redline S., Yenokyan G., Gottlieb D.J., Shahar E., O'Connor G.T., Resnick H.E., et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010, 182(2):269-277.
8. Arzt M., Young T., Finn L., Skatrud J., Bradley T. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005, 172:1447-1451.
9. Botros N., Concato J., Mohsenin V., Selim B., Doctor K., Yaggi H.K. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009, 122(12):1122-1127.
10. Punjabi N.M., Sorkin J.D., Katzel L.I., Goldberg A.P., Schwartz A.R., Smith P.L. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Med 2002, 165(5):677-682.
11. Punjabi N.M., Shahar E., Redline S., Gottlieb D.J., Givelber R., Resnick H.E. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the sleep heart health study. Am J Epidemiol 2004, 160(6):521-530.
12. West S.D., Nicoll D.J., Wallace T.M., Matthews D.R., Stradling J.R. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007, 62(11):969-974.
13. Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354(9188):1435-1439.
14. Stamatakis K.A., Punjabi N.M. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 2010, 137(1):95-101.
15. Weitzman E.D. Circadian rhythms and episodic hormone secretion in man. Ann Rev Med 1976, 27:225-243.
16. Dzaja A., Dalal M.A., Himmerich H., Uhr M., Pollmacher T., Schuld A., et al. Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. Am J Physiol Endocrinol Metab 2004, 286(6):E963-E967.
17. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S., et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50(8):1714-1719.
18. Yildiz B.O., Suchard M.A., Wong M.L., McCann S.M., Licinio J. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci U S A 2004, 101(28):10434-10439.
19. Kalsbeek A., Fliers E., Romijn J.A., la Fleur S.E., Wortel J., Bakker O., et al. The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. Endocrinology 2001, 50(6):2677-2685.
20. Karakas A., Gunduz B. Suprachiasmatic nuclei may regulate the rhythm of leptin hormone release in Syrian hamsters (Mesocricetus Auratus). Chronobiol Int 2006, 23(1-2):225-236.
21. Arendt J. Melatonin and human rhythms. Chronobiol Int 2006, 23(1-2):21-37.
22. Sack R.L., Auckley D., Auger R.R., Carskadon M.A., Wright K.P., Vitiello M.V., et al. Circadian rhythm sleep disorders: Part I, Basic principles, shift work and jet lag disorders: an American academy of sleep medicine review. Sleep 2007, 30(11):1460-1483.
23. Lewy A.J., Sack R.L. The dim light melatonin onset as a marker for circadian phase position. Chronobiol Int 1989, 6(1):93-102.
24. Gooneratne N.S., Metlay J.P., Guo W., Pack F.M., Kapoor S., Pack A.I., et al. The validity and feasibility of saliva melatonin assessment in the elderly. J Pineal Res 2003, 34(2):88-94.
25. Lewy A.J., Cutler N.L., Sack R.L. The endogenous melatonin profile as a marker for circadian phase position. J Biol Rhythms 1999, 14(3):227-236.
26. Van Cauter E., Moreno-Reyes R., Akseki E., L'Hermite-Baleriaux M., Hirschfeld U., Leproult R., et al. Rapid phase advance of the 24-h melatonin profile in response to afternoon dark exposure. Am J Physiol 1998, 275(1 Pt 1):E48-E54.
27. Lewy A.J., Tetsuo M., Markey S.P., Goodwin F.K., Kopin I.J. Pinealectomy abolishes plasma melatonin in the rat. J Clin Endocrinol Metab 1980, 50(1):204-205.
28. Sitaram B.R., Sitaram M., Traut M., Chapman C.B. Nyctohemeral rhythm in the levels of S-adenosylmethionine in the rat pineal gland and its relationship to melatonin biosynthesis. J Neurochem 1995, 65(4):1887-1894.
29. Lewy A.J. Effects of light on human melatonin production and the human circadian system. Prog Neuropsychopharmacol Biol Psychiatry 1983, 7(4-6):551-556.
30. Trinder J., Armstrong S.M., O'Brien C., Luke D., Martin M.J. Inhibition of melatonin secretion onset by low levels of illumination. J Sleep Res 1996, 5(2):77-82.
31. Laakso M.L., Hätönen T., Stenberg D., Alila A., Smith S. One-hour exposure to moderate illuminance (500lux) shifts the human melatonin rhythm. J Pineal Res 1993, 15(1):21-26.
32. Van Cauter E., Sturis J., Byrne M.M., Blackman J.D., Leproult R., Ofek G., et al. Demonstration of rapid light-induced advances and delays of the human circadian clock using hormonal phase markers. Am J Physiol 1994, 266(6 Pt 1):E953-E963.
33. Deacon S., Arendt J. Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans. Brain Res 1995, 688(1-2):77-85.
34. Buxton O.M., L'Hermite-Baleriaux M., Turek F.W., van Cauter E. Daytime naps in darkness phase shift the human circadian rhythms of melatonin, thyrotropin secretion. Am J Physiol Regul Integr Comp Physiol 2000, 278(2):R373-R382.
35. Röjdmark S., Berg A., Rössner S., Wetterberg L. Nocturnal melatonin secretion in thyroid disease and in obesity. Clin Endocrinol (Oxf) 1991, 35(1):61-65.
36. Nathan P.J., Jeyaseelan A.S., Burrows G.D., Norman T.R. Modulation of plasma melatonin concentrations by changes in posture. J Pineal Res 1998, 24(4):219-223.
37. Hanssen T., Heyden T., Sundberg I., Wetterberg L. Effect of propranolol on serum-melatonin. Lancet 1977, 2(8032):309-310.
38. Weitzman E.D. Biologic rhythms and hormone secretion patterns. Hosp Pract 1976, 11(8):79-86.
39. Entzian P., Linnemann K., Schlaak M., Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996 Mar, 153(3):1080-1086.
40. Dadoun F., Darmon P., Achard V., Boullu-Ciocca S., Philip-Joet F., Alessi M.C., et al. Effect of sleep apnea syndrome on the circadian profile of cortisol in obese men. Am J Physiol Endocrinol Metab 2007, 293(2):E466-E474.
41. Hernandez C., Abreu J., Abreu P., Castro A., Jimenez A. Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP. Eur Resp J 2007, 30(3):496-500.
42. Wikner J., Svanborg E., Wetterberg L., Röjdmark S. Melatonin secretion and excretion in patients with obstructive sleep apnea syndrome. Sleep 1997, 20(11):1002-1007.
43. Ulfberg J., Micic S., Strom J. Afternoon serum-melatonin in sleep disordered breathing. J Intern Med 1998, 244(2):163-168.
44. Brzecka A., Piesiak P., Zareba-Bogdał E., Zierkiewicz G., Plamieniak Z. Rhythm of melatonin excretion in obstructive sleep apnea syndrome. Pneumonol Alergol Pol 2001, 69(11-12).